Charles Balch resigns as ASCO executive vice president; Joseph Bailes named interim EVP.
Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.
Senate approves NIH funding bill. NCI awards $25 million to eight institutions for patient navigator programs; $35 million awarded for nanotechnology partnerships.
NIH-funded HapMap consortium publishes first phase of catalog.
NIH begins transition to electronic grant submissions; seeks comment on options for NRSA funding.
Trending Stories
- Joe Fraumeni, founder of molecular epidemiology, dies at 93
“It’s hard to imagine a world without the presence of this gentle scientific giant.” - Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions” - Robert Mayer tells us about pancreatic cancer’s hopeless past as new data shows promise
- Dana-Farber names its under-construction freestanding hospital: the Lavine Bekenstein Cancer Hospital
- To keep the early clinical trial enterprise in the U.S., HHS pledges to simplify regulatory requirements









